A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications

Journal of Diabetes Research
Francesca ConservaMassimo Papale

Abstract

Diabetic nephropathy (DN), a microvascular complication occurring in approximately 20-40% of patients with type 2 diabetes mellitus (T2DM), is characterized by the progressive impairment of glomerular filtration and the development of Kimmelstiel-Wilson lesions leading to end-stage renal failure (ESRD). The causes and molecular mechanisms mediating the onset of T2DM chronic complications are yet sketchy and it is not clear why disease progression occurs only in some patients. We performed a systematic analysis of the most relevant studies investigating genetic susceptibility and specific transcriptomic, epigenetic, proteomic, and metabolomic patterns in order to summarize the most significant traits associated with the disease onset and progression. The picture that emerges is complex and fascinating as it includes the regulation/dysregulation of numerous biological processes, converging toward the activation of inflammatory processes, oxidative stress, remodeling of cellular function and morphology, and disturbance of metabolic pathways. The growing interest in the characterization of protein post-translational modifications and the importance of handling large datasets using a systems biology approach are also discussed.

References

Nov 1, 1975·Journal of Ultrastructure Research·P P De BruynR P Becker
Nov 8, 1996·Science·M R Emmert-BuckL A Liotta
Feb 3, 1999·Annals of the New York Academy of Sciences·A R HipkissN J Abbott
Mar 29, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Gianna MazzuccoGuido Monga
Sep 28, 2002·Diabetes·David E KelleyVladimir B Ritov
Nov 13, 2002·Kidney International·Irfan VardarliBart Janssen
Mar 29, 2003·European Journal of Clinical Investigation·K C B TanY Wong
Jun 17, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Robyn G LanghamNapier M Thomson
Jan 23, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Masao ToyodaHideto Sakai
Mar 26, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hans J BaeldeJan A Bruijn
Aug 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Trairak PisitkunMark A Knepper
Oct 2, 2004·Kidney International·Donald W BowdenBarry I Freedman
Feb 3, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Yoshinobu KanesakiTsuyoshi Watanabe
Jun 16, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vincent DolanHugh R Brady
Jul 6, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Cheuk-Chun SzetoFernand Mac-Moune Lai
Sep 7, 2006·Kidney International·J M Weinberg
Oct 27, 2006·Diabetes·Holger SchmidUNKNOWN European Renal cDNA Bank (ERCB) Consortium
Jan 11, 2007·Journal of Clinical Pathology·K O Alsaad, A M Herzenberg
Feb 3, 2007·Journal of Proteome Research·Hyun-Jung KimChan-Wha Kim
Mar 10, 2007·Nephron. Experimental Nephrology·Hua SunLei-shi Li
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Giovanni G CamiciFrancesco Cosentino
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mitsuo KatoRama Natarajan
May 4, 2007·Journal of the American Society of Nephrology : JASN·Maja T LindenmeyerClemens D Cohen
Sep 25, 2007·European Journal of Clinical Investigation·J GerthG Wolf
Nov 6, 2007·Biochimica Et Biophysica Acta·David W WalshFinian Martin
Dec 11, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Jürgen GeiselWolfgang Herrmann
Feb 22, 2008·Journal of the American Society of Nephrology : JASN·Corina LorzAlberto Ortiz
May 2, 2008·Journal of the American Society of Nephrology : JASN·Kasper RossingUNKNOWN PREDICTIONS Network
May 30, 2008·Journal of the American Society of Nephrology : JASN·Madeline MurphyFinian Martin
Jun 14, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Holly KramerMichael Shlipak
Jul 16, 2008·Journal of Proteomics·Xiangming Fang, Wei-Wei Zhang

❮ Previous
Next ❯

Citations

Jan 27, 2017·Phytotherapy Research : PTR·Aline Maria StolfAlexandra Acco
Jan 24, 2017·Medwave·Carlos Eduardo Meza LetelierCristobal Jesus Frugone Zaror
Sep 19, 2019·Archives of Physiology and Biochemistry·Manal S FawzyWalla Alelwani
Sep 29, 2017·Critical Reviews in Clinical Laboratory Sciences·Nektaria Papadopoulou-MarketouIoannis Papassotiriou
Feb 7, 2017·Muscle & Nerve·Curtis A NutterMuge N Kuyumcu-Martinez
Sep 1, 2016·Personalized Medicine·Adriana Fodor, Eddy Karnieli
Sep 17, 2020·International Journal of Molecular Sciences·Sebastian MertowskiWojciech Załuska
Dec 28, 2017·Wiley Interdisciplinary Reviews. RNA·Curtis A Nutter, Muge N Kuyumcu-Martinez

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
electrophoresis
genotyping
PCR
RNA-Seq
biopsy
biopsies
transgenic
Laser Capture Microdissection
ELISA

Software Mentioned

miRNome

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Diabetes/metabolism Research and Reviews
Wei-Jian NiWei Wei
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Katerina KankováVladimír Znojil
© 2022 Meta ULC. All rights reserved